S

Saul J. Priceman

University of Southern California

ORCID: 0000-0002-8136-2112

Publishes on CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune cells in cancer. 208 papers and 9k citations.

PubIndex Score99Top 1% · mid-careerHow it's scored

🌱#4 Emerging Leader in Viral Infectious Diseases and Gene Expression in Insects 🌱#8 Emerging Leader in Cytokine Signaling Pathways and Interactions 🌱#9 Emerging Leader in Adipokines, Inflammation, and Metabolic Diseases

208Publications

9kTotal Citations

#4in Viral Infectious Diseases and Gene Expression in Insects

First publication: 2006First senior author: 2016

CAR-T cell therapy research Immunotherapy and Immune Responses Immune cells in cancer Cancer Immunotherapy and Biomarkers Virus-based gene therapy research

Top publicationsby citations

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

Christine E. Brown, Behnam Badie, Xiuli Wang et al.|New England Journal of Medicine|2016

Cited by 1.8k

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages

Yukiko Yamaguchi, Saul J. Priceman|Journal for ImmunoTherapy of Cancer|2022

Cited by 111

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

Eric Hee Jun Lee, Saul J. Priceman|Nature Communications|2023

Cited by 102

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

Eric Hee Jun Lee, Saul J. Priceman|bioRxiv (Cold Spring Harbor Laboratory)|2023

Cited by 10

PD-L1 blockade restores CAR T cell activity through IFNγ-regulation of CD163+ macrophages

Yukiko Yamaguchi, Saul J. Priceman|bioRxiv (Cold Spring Harbor Laboratory)|2022

Cited by 1